Management

Paul joined the company in 2012 as head of Cellectricon’s Discovery Services and is now responsible for deal-making and business development in his role as CBO. He previously worked at AstraZeneca (AZ) where he held leadership positions at the Departments of Molecular Pharmacology and Neuroscience. At AZ, Paul led teams responsible for target identification/target validation and ion channel and GPCR profiling in LI-LO phase, mainly in chronic pain and neuropsychiatry projects. Prior to joining AZ, Paul was a Postdoctoral Fellow at School of Medicine, University of Pittsburgh, USA, studying neurobiology using electrophysiological methods. He has a PhD in physiology from University of Gothenburg, Sweden.

Lotta joined the company in early 2023 as the Laboratory Operations Manager and is now responsible for developing and overseeing the discovery services in her role as COO. Before joining the company, she was a researcher at the University of Gothenburg, where she established and implemented iPSC-based cellular models for Alzheimer’s disease pathology and biomarker biology. Lotta has more than 10 years of experience in in vitro neurodegeneration research and human iPSC-based cellular models for neuroscience. Before joining the group of Henrik Zetterberg at the University of Gothenburg as a PostDoc, she received a PhD in medical sciences from the University of Linköping.

Kristina was appointed CFO of Cellectricon in 2016. She has over 25 years of experience from similar positions, operating in both large and small corporate groups. Prior to joining Cellectricon, Kristina has worked in auditing, wholesale, and finance in different roles as accounting manager and CFO.